ChatGPT, Claude, Gemini의 AI 대화를 저장하고, 새 채팅에서 관련 컨텍스트를 자동으로 제안하여 생산성을 향상시키는 Chrome 확장 프로그램입니다.
SubSync는 다중 스레드 사고 환경을 도입하여 AI 대화를 혁신하는 Chrome 사이드바 확장 프로그램입니다. 사용자가 ChatGPT 또는 Claude와 같은 AI 모델과 병렬 대화를 진행하면서도 주 채팅 컨텍스트를 그대로 유지할 수 있도록 합니다. 이 혁신적인 접근 방식은 비선형적 사고를 지원하여 전문가들이 더 깊이 탐색하고, 빠르게 실험하며, AI를 보다 효과적으로 활용할 수 있도록 돕습니다.
제품 개요
Memdex 제품 개요
ChatGPT, Claude, Gemini의 AI 대화를 저장하고, 새 채팅에서 관련 컨텍스트를 자동으로 제안하여 생산성을 향상시키는 Chrome 확장 프로그램입니다.
SubSync 제품 개요
SubSync는 다중 스레드 사고 환경을 도입하여 AI 대화를 혁신하는 Chrome 사이드바 확장 프로그램입니다. 사용자가 ChatGPT 또는 Claude와 같은 AI 모델과 병렬 대화를 진행하면서도 주 채팅 컨텍스트를 그대로 유지할 수 있도록 합니다. 이 혁신적인 접근 방식은 비선형적 사고를 지원하여 전문가들이 더 깊이 탐색하고, 빠르게 실험하며, AI를 보다 효과적으로 활용할 수 있도록 돕습니다.
Detailed feature comparison
| Feature | Memdex | SubSync |
|---|---|---|
| 주요 카테고리 | 워크플로우 자동화 | Ai Assistant |
| 등록일 | 2026-05-25 | 2026-01-16 |
| 가격 | 프리미엄 | 확인되지 않음 |
| 공식 사이트 | memdex.ai | subsync.super.site |
| 제품 유형 | 브라우저 확장 | 브라우저 확장 |
| Performance data | ||
| 사용자 평점 | 확인되지 않음 | 확인되지 않음 |
| 댓글 | 0 | 0 |
| 월 방문 | 3.7K | 3.5K |
| 월 성장률 | 확인되지 않음 | 확인되지 않음 |
| 즐겨찾기 | 0 | 12 |
| Details | 상세 보기 | 상세 보기 |
Memdex vs SubSync monthly traffic
Compare Memdex and SubSync by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Memdex vs SubSync monthly traffic comparison, Memdex currently shows 3.7K visits and SubSync shows 3.5K; the two products have similar visible traffic, an absolute difference of about 150 visits. This reflects visible reach, not feature quality or paid users.
Both values come from visits recorded inside ToolMage. They can indicate relative interest on this site, but not total website traffic or global market share.
Memdex monthly traffic:
Latest traffic
SubSync monthly traffic:
Latest traffic
Usage comparison
Compare the core capabilities of Memdex and SubSync
Memdex Core features
SubSync Core features
Use cases
Memdex Use cases
SubSync Use cases
Best suited roles
Memdex Best suited roles
SubSync Best suited roles
Memdex vs SubSync:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Memdex vs SubSync comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Memdex is primarily listed under “워크플로우 자동화”, while SubSync is primarily listed under “Ai Assistant”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Memdex: 워크플로우 자동화; SubSync: Ai Assistant); Pricing (Memdex: Freemium; SubSync: Not disclosed); Monthly visits (Memdex: 3.7K; SubSync: 3.5K); Favorites (Memdex: 0; SubSync: 12); Website (Memdex: memdex.ai; SubSync: subsync.super.site). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Memdex vs SubSync monthly traffic comparison, Memdex currently shows 3.7K visits and SubSync shows 3.5K; the two products have similar visible traffic, an absolute difference of about 150 visits. This reflects visible reach, not feature quality or paid users.
Both values come from visits recorded inside ToolMage. They can indicate relative interest on this site, but not total website traffic or global market share.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
Memdex and SubSync currently overlap in shared categories: 워크플로우 자동화; shared tags: ChatGPT, Claude, Gemini 및 생산성; shared roles: 콘텐츠 크리에이터, 마케팅 매니저 및 연구원. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Memdex's unique categories/tags are AI 대화, 채팅 기록, 크롬 확장 프로그램, 컨텍스트 관리 및 로컬 스토리지; SubSync's are Ai Assistant, Learning Tools, 프롬프트 엔지니어링, AI 채팅, 브레인스토밍, 브라우저 확장 프로그램, 디버깅 및 학습. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Memdex has no verified rating, 0 comments, 0 favorites, and 0 likes;SubSync has no verified rating, 0 comments, 12 favorites, and 10 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Memdex first
Put Memdex on the priority trial list when the task aligns with “워크플로우 자동화” and especially AI 대화, 채팅 기록, 크롬 확장 프로그램, 컨텍스트 관리 및 로컬 스토리지, or the users include 데이터 분석가, 프로덕트 매니저 및 소프트웨어 개발자. This follows recorded positioning and does not imply unlisted capabilities are absent.
Memdex also currently records: pricing is freemium, product type is browser extension, 3.7K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate SubSync first
Put SubSync on the priority trial list when the task aligns with “Ai Assistant” and especially Ai Assistant, Learning Tools, 프롬프트 엔지니어링, AI 채팅, 브레인스토밍 및 브라우저 확장 프로그램, or the users include AI 개발자, 엔지니어, 설립자 및 학생. This follows recorded positioning and does not imply unlisted capabilities are absent.
SubSync also currently records: pricing is not verified, product type is browser extension, 3.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Memdex and SubSync, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




